
Juliana Maynard
Director of Operations and Engagement for the National PET Imaging Platform and Head of Translational Imaging at Medicines Discovery Catapult, UK
Director of Operations and Engagement for the National PET Imaging Platform and Head of Translational Imaging at Medicines Discovery Catapult, UK
March 5, 2025
Radiopharmaceuticals are a promising approach to cancer, but some countries, including the UK, are lagging behind. A collaboration hopes to change that.
6 min read
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
False
False